MADRIGAL PHARMACEUTICALS, INC. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
MDGL on Nasdaq
Location
West Conshohocken, PA
Fiscal year end
31 December
Latest financial report
19 Feb 2026

Quick Takeaways

  • MDGL - MADRIGAL PHARMACEUTICALS, INC. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Equity -42%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-47%</span>.
  • Most recent SEC facts end date: 12 Feb 2026.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2026-02-12) highlights Return On Equity -42.5%, Return On Assets -16.3%, and Operating Margin -18.6%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

47.1/100

Caution Confidence high

Return On Equity

-42%

Metric score 0.0/100

Return On Assets

-16%

Metric score 0.0/100

Financial Health

Current Ratio
4.02x
Quick Ratio
3.6x
Debt to Equity
0.58x

Strengths

Debt-to-equity, Revenues YoY, and NetIncomeLoss YoY

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Return On Equity

-42%

YoY: -47%

Industry median: -43% (n=671)

View history

Return On Assets

-16%

YoY: -55%

Industry median: -48% (n=669)

View history

Operating Margin

-19%

YoY: -89%

Industry median: -128% (n=298)

View history

Current Ratio

4.02x

YoY: -34%

Industry median: 3.39x (n=667)

View history

Quick Ratio

3.6x

YoY: -82%

Industry median: 2.02x (n=287)

View history

Debt-to-equity

0.58x

YoY: +132%

Industry median: 0.28x (n=634)

View history

Revenues YoY

432%

YoY:

Industry median: 5% (n=103)

View history

NetIncomeLoss YoY

38%

YoY:

Industry median: -0.54% (n=641)

View history

Profitability

Metric Latest value YoY change
Return On Equity -42% -47%
Return On Assets -16% -55%
Operating Margin -19% -89%

Financial Health

Metric Latest value YoY change
Current Ratio 4.02x -34%
Quick Ratio 3.6x -82%
Debt-to-equity 0.58x +132%

Growth

Metric Latest value YoY change
Revenues YoY 432%
NetIncomeLoss YoY 38%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 22,939,969
Common Stock, Shares, Outstanding 22,842,073 +3.8%
Common Stock, Value, Issued $2,000 0%
Weighted Average Number of Shares Outstanding, Basic 22,434,310 +5.5%
Weighted Average Number of Shares Outstanding, Diluted 22,434,310 +5.5%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $958,403,000 +432%
Operating Income (Loss) $300,097,000 +40%
Earnings Per Share, Basic -12.85 +41%
Earnings Per Share, Diluted -12.85 +41%
Cash and Cash Equivalents, at Carrying Value $198,693,000 +99%
Accounts Receivable, after Allowance for Credit Loss, Current $134,476,000 +150%
Inventory, Net $74,841,000 +120%
Assets, Current $1,245,770,000 +21%
Property, Plant and Equipment, Net $1,499,000 -32%
Operating Lease, Right-of-Use Asset $4,939,000 +106%
Assets $1,259,589,000 +21%
Accounts Payable, Current $48,878,000 +12%
Employee-related Liabilities, Current $69,211,000 +102%
Accrued Liabilities, Current $260,392,000 +109%
Liabilities, Current $310,288,000 +83%
Operating Lease, Liability, Noncurrent $6,731,000 +561%
Liabilities $656,900,000 +128%
Accumulated Other Comprehensive Income (Loss), Net of Tax $873,000 +87%
Retained Earnings (Accumulated Deficit) $2,090,466,000 -16%
Stockholders' Equity Attributable to Parent $602,689,000 -20%
Liabilities and Equity $1,259,589,000 +21%
Common Stock, Shares Authorized 200,000,000 0%
Common Stock, Shares, Issued 22,842,073 +3.8%
Common Stock, Par or Stated Value Per Share 0.0001 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $203,783,000 +94%
Deferred Tax Assets, Valuation Allowance $591,049,000 +16%
Deferred Tax Assets, Gross $591,411,000 +16%
Operating Lease, Liability $7,749,000 +287%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $287,879,000 +38%
Lessee, Operating Lease, Liability, to be Paid $10,282,000 +363%
Operating Lease, Liability, Current $1,018,000 +3.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,065,000 +93%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,242,000 +8%
Operating Lease, Weighted Average Discount Rate, Percent 0.1004 -5.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,533,000 +1046%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,102,000
Preferred Stock, Shares Issued 2,369,797 0%
Preferred Stock, Shares Authorized 5,000,000 0%
Unrecognized Tax Benefits $12,058,000
Lessee, Operating Lease, Liability, to be Paid, Year Four $2,140,000
Preferred Stock, Shares Outstanding 2,369,797 0%
Deferred Tax Assets, Net of Valuation Allowance $362,000 +67%
Share-based Payment Arrangement, Expense $98,130,000 +23%
Preferred Stock, Par or Stated Value Per Share 0.0001 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY